PHAR.EGX Egyptian International Pharmaceuticals (EIPICO)
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is PHAR.EGX undervalued?
Graham numberThe Graham number of Egyptian International Pharmaceuticals (EIPICO) cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Egyptian International Pharmaceuticals (EIPICO) fundamental analysis
No fundamental analysis for Egyptian International Pharmaceuticals (EIPICO) yet.
Egyptian International Pharmaceuticals (EIPICO) stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
Financial statements of Egyptian International Pharmaceuticals (EIPICO) are not available yet.
Egyptian International Pharmaceuticals (EIPICO) dividends
Egyptian International Pharmaceuticals (EIPICO) has not paid dividends in the last 1 fiscal years.
Who owns Egyptian International Pharmaceuticals (EIPICO)
Ownership data of Egyptian International Pharmaceuticals (EIPICO) is not available yet.
Egyptian International Pharmaceuticals (EIPICO) company profile
- Company name
- Egyptian International Pharmaceuticals (EIPICO)
- Ticker
- PHAR.EGX
- ISIN
- EGS38081C013
- Exchange
- Egyptian Exchange
- Sector
- -
- Industry
- -
- Address
- Website
- -